GCIA
AVEO

Gabelli & Co Investment Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-119,150
Closed -$1.78M – 336
2022
Q4 		$1.78M Buy
+119,150
New +$1.65M 0.38% 53

Gabelli & Co Investment Advisers's AVEO Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 119,150 shares — an estimated $1.78M sold.

Gabelli & Co Investment Advisers first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $1.78M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Gabelli & Co Investment Advisers reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 119,150 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.78M.
  • Gabelli & Co Investment Advisers first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's AVEO Pharmaceuticals, Inc. position peaked at $1.78M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.